Vitrolife Group

Vitrolife Group stands as a world-leading global provider of medical devices and genetic testing solutions, demonstrating excellence in reproductive health since 1994. With a steadfast commitment to product development, groundbreaking research, and consistent quality control, Vitrolife Group has expanded its capabilities through strategic acquisitions of innovative companies within the industry. The acquisition of Igenomix in 2021, a leader in reproductive genetic testing services for IVF clinics, further solidified Vitrolife Group's position as a global leader.

Vitrolife Group is dedicated to supporting customers and patients worldwide, aiming to improve treatment outcomes while maintaining a strong focus on sustainability. Grounded in science and advanced research, the company strives to deliver products and services that cater to the entire reproductive health journey, ensuring consistent performance and guaranteed quality. With a global presence, Vitrolife Group operates in over 125 countries through its own presence in more than 25 countries and a broad network of distributors.

Driven by a mission to be the leading valued solution provider in reproductive health, Vitrolife Group is committed to supporting customers in achieving successful treatment outcomes. We invite the management team of Vitrolife Group to enhance your presence on our platform with a customized and exclusive company showcase and product listing, highlighting your contributions to the field.